Format

Send to

Choose Destination
Mediators Inflamm. 2015;2015:984570. doi: 10.1155/2015/984570. Epub 2015 Oct 11.

Treatment of Cancer Pain by Targeting Cytokines.

Author information

1
Medical Oncology Department, Santa Maria Hospital, Northern Lisbon Hospital Center, Avenida Professor Egas Moniz, 1649-035 Lisbon, Portugal.
2
Costa Lab, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-035 Lisboa, Portugal.
3
Medical Oncology Department, Santa Maria Hospital, Northern Lisbon Hospital Center, Avenida Professor Egas Moniz, 1649-035 Lisbon, Portugal ; Costa Lab, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-035 Lisboa, Portugal.

Abstract

Inflammation is one of the most important causes of the majority of cancer symptoms, including pain, fatigue, cachexia, and anorexia. Cancer pain affects 17 million people worldwide and can be caused by different mediators which act in primary efferent neurons directly or indirectly. Cytokines can be aberrantly produced by cancer and immune system cells and are of particular relevance in pain. Currently, there are very few strategies to control the release of cytokines that seems to be related to cancer pain. Nevertheless, in some cases, targeted drugs are available and in use for other diseases. In this paper, we aim to review the importance of cytokines in cancer pain and targeted strategies that can have an impact on controlling this symptom.

PMID:
26538839
PMCID:
PMC4619962
DOI:
10.1155/2015/984570
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Hindawi Limited Icon for PubMed Central
Loading ...
Support Center